Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
17.92
-0.58 (-3.14%)
At close: Feb 13, 2026, 4:00 PM EST
17.85
-0.07 (-0.39%)
After-hours: Feb 13, 2026, 7:34 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Novel Small Molecule Precision Medicines
75.62M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
75.62M